Delivery Order SPE2DR25D3103-SPE2DR26F9P90
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for Xylocaine-MPF 2% (40 mg/2 mL vials) with a ceiling value of $1,253.12. This non-set-aside, firm fixed-price delivery order is expected to be completed by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain managed by the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xylocaine-MPF 1% Vial 5ML, a local anesthetic medication commonly used in medical and surgical applications. This firm fixed-price delivery order, valued at $2,413.46, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $5,858.87 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 10mL units. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by August 21, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,272.65 delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Xylocaine 2%-Epinephrine 1:200,000, a local anesthetic with vasoconstrictor properties commonly used in medical and surgical procedures. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,643.42 for Xylocaine 2%-Epinephrine 1:200,000 (20mL), a local anesthetic with vasoconstrictor commonly used in medical and surgical procedures. This firm fixed price delivery order, awarded November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-set-aside competitive award. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,060.82 to AmerisourceBergen Drug Corp for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 20ml vials, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued...
- The Defense Logistics Agency awarded a $244,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 50ml vials of 1% xylocaine. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products to a facility in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The delivery order was issued against an existing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Xylocaine 2%-Epinephrine 1:200,000 20mL, a local anesthetic with vasoconstrictor agent commonly used in surgical and dental procedures. This firm fixed-price delivery order, valued at $1,022.62, was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The award was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,536.32. The order is for the supply of XYLOCAINE-MPF 2% VIAL 2ML, a local anesthetic medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 26, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded a $275 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561844177 XYLOCAINE-MPF 1% vials. The contract calls for Amerisourcebergen to deliver 30mL vials of XYLOCAINE-MPF 1% anesthetic from its facility in Conshohocken, Pennsylvania to an unspecified customer or customers of the Defense Logistics Agency. The delivery order was issued on August 17, 2023 and work under the contract must be completed by August 18,...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9P90Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,233.50 to AmerisourceBergen Drug Corp for the supply of Xylocaine-MPF 1% vials (5mL) on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. Xylocaine-MPF is a local anesthetic commonly used in medical procedures and emergency response applications throughout the Department of Defense healthcare system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. Through this vehicle, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, serving entities including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitive awards across multiple therapeutic domains demonstrates its established capability to fulfill federal medical supply requirements efficiently and cost-effectively.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/15/25 |